GLA c.168C>A ;(p.C56*)

Variant ID: X-100662724-G-T

NM_000169.2(GLA):c.168C>A;(p.C56*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants.

Rna Biology
Lombardi, Silvia S; Ferrarese, Mattia M; Marchi, Saverio S; Pinton, Paolo P; Pinotti, Mirko M; Bernardi, Francesco F; Branchini, Alessio A
Publication Date: 2020-02

Variant appearance in text: GLA: C56X
PubMed Link: 31613176
Variant Present in the following documents:
  • Main text
View BVdb publication page



Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease.

Jimd Reports
Goker-Alpan, Ozlem O; Gambello, Michael J MJ; Maegawa, Gustavo H B GH; Nedd, Khan J KJ; Gruskin, Daniel J DJ; Blankstein, Larry L; Weinreb, Neal J NJ
Publication Date: 2016

Variant appearance in text: GLA: C56X
PubMed Link: 26303609
Variant Present in the following documents:
  • Main text
View BVdb publication page